Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities
Net loss	$ (577,881)	$ (600,923)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation to related parties	19,600
Loss on derivative liabilities	(18,134)	66,532
Change in fair value of derivative liabilities	44,336	(142,306)
Amortization of prepaid stock-based compensation	60,943	303,056
Amortization of debt discount	106,664	134,031
Patent amortization	74,194	5,693
Depreciation	2,720	1,163
Changes in operating assets and liabilities:
Accounts receivable	7,672	(19,721)
Inventory	6,743	383
Prepaid expenses and other current assets	37,605	17,021
Right-of-use asset	10,630	6,261
Accounts payable	(10,283)	(21,586)
Accounts payable - related parties	8	(2,451)
Accrued expenses and other current liabilities	44,735	44,243
Lease liability	(10,630)	(6,261)
Net cash used in operating activities	(201,078)	(214,865)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of license		(200,000)
Issuance of note receivable	1,951
Net cash used in investing activities	1,951	(200,000)
Cash flows from financing activities
Payments on notes payable to related party	(8)	(2,404)
Proceeds from convertible notes payable	70,750	145,000
Payments on notes payable	(1,210)	(1,077)
Proceeds from sale of common stock	130,086	345,000
Net cash provided by financing activities	199,618	486,519
Net increase (decrease) in cash, cash equivalents and restricted cash	491	71,654
Cash, cash equivalents and restricted cash at beginning of period	29,043	104,259
Cash, cash equivalents and restricted cash at end of period	29,534	175,913
Supplemental cash flow information:
Cash paid for interest	663	710
Cash paid for income taxes
Non-cash investing and financing transactions:
Original issuance discount on convertible notes payable	8,500	11,250
Debt discount recorded in connection with derivative liability	69,565	145,000
Common stock issued in conversion of convertible notes payable and interest	188,459	228,365
Common stock issued for accrued salaries	20,000	29,999
Accrued interest added to principal	6,479	6,478
Common stock issued for license	146,244	3,107,570
Common stock issued for subscription receivable		100,000
Right of use asset and lease liability	146,244
Reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheets:
Cash and cash equivalents	18,531	165,690
Restricted cash	11,003	10,223
Total cash, cash equivalents, and restricted cash shown in the consolidated statements of cash flows:	$ 29,534	$ 175,913